Katherine Harris, PhDSenior Director of Discovery at TeneoBio Inc.
Katherine Harris is currently Director of Discovery at Teneobio and leads a group focused on antibody discovery. She co-developed a novel sequence-based discovery approach using NGS, bioinformatics and high-throughput recombinant protein expression and screening to identify large collections of sequence-defined and functionally validated antibodies. Her experience also includes development of multi-valent and multi-specific antibody therapeutics. Prior to her work at Teneobio, she was a research scientist at Active Motif and SwitchGear Genomics where she focused her efforts on developing a functional genomics platform for small molecule screening. Dr. Katherine Harris holds a Ph.D. in Molecular and Cell Biology from the University of California, Berkeley.